Login / Signup

Estimating optimal therapeutic drug levels of anti-tuberculosis medications based on treatment safety and effectiveness.

Gustavo AmorimDavid W HaasMarcelo Cordeiro-SantosAfrânio L KritskiMarina C FigueiredoCody StaatsBrian HacheyMegan TurnerBruno Bezerril AndradeValeria C RollaTimothy R Sterlingnull null
Published in: medRxiv : the preprint server for health sciences (2024)
Our estimated upper end TDR were higher for INH and lower for RIF compared to currently recommended ranges.
Keyphrases
  • pulmonary tuberculosis
  • randomized controlled trial
  • mycobacterium tuberculosis
  • systematic review
  • adverse drug
  • hiv aids
  • emergency department
  • combination therapy
  • drug induced